These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12485960)

  • 1. Amino acid conjugates: metabolites of 2-propylpentanoic acid (valproic acid) in epileptic patients.
    Gopaul VS; Tang W; Farrell K; Abbott FS
    Drug Metab Dispos; 2003 Jan; 31(1):114-21. PubMed ID: 12485960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabolites of valproic acid in epileptic patients.
    Katayama H; Watanabe M; Yoshitomi H; Yoshida H; Kimoto H; Kamiya A; Hayashi T; Akimura T
    Biol Pharm Bull; 1998 Mar; 21(3):304-7. PubMed ID: 9556166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of valproic acid and its metabolites by gas chromatography-mass spectrometry with selected ion monitoring.
    Tatsuhara T; Muro H; Matsuda Y; Imai Y
    J Chromatogr; 1987 Jul; 399():183-95. PubMed ID: 3116023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy.
    Löscher W; Nau H; Siemes H
    Epilepsia; 1988; 29(3):311-6. PubMed ID: 3131137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.
    Gopaul SV; Farrell K; Abbott FS
    J Mass Spectrom; 2000 Jun; 35(6):698-704. PubMed ID: 10862121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid elimination rate and urinary excretion of its glucuronide conjugate in patients with epilepsy.
    Yoshida H; Hirozane K; Kimoto H; Hayashi T; Akiyama T; Katayama H; Watanabe M; Yoshitomi H; Kamiya A
    Biol Pharm Bull; 1999 Jul; 22(7):716-20. PubMed ID: 10443469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S; Farrell K; Abbott F
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of aspirin on valproic acid metabolism.
    Abbott FS; Kassam J; Orr JM; Farrell K
    Clin Pharmacol Ther; 1986 Jul; 40(1):94-100. PubMed ID: 3087680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of valproate and some metabolites in chronically treated patients.
    Dickinson RG; Hooper WD; Dunstan PR; Eadie MJ
    Ther Drug Monit; 1989; 11(2):127-33. PubMed ID: 2497561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiling of valproic acid in patients using negative-ion chemical ionization gas chromatography-mass spectrometry.
    Kassahun K; Farrell K; Zheng JJ; Abbott F
    J Chromatogr; 1990 May; 527(2):327-41. PubMed ID: 2117614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry.
    Fisher E; Wittfoht W; Nau H
    Biomed Chromatogr; 1992; 6(1):24-9. PubMed ID: 1600371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.
    Iinuma K; Hayasaka K; Narisawa K; Tada K; Hori K
    Eur J Pediatr; 1988 Dec; 148(3):267-9. PubMed ID: 3145882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of valproic acid metabolites in human serum and urine using hexadeuterated valproic acid and gas chromatographic mass spectrometric analysis.
    Acheampong A; Abbott F; Burton R
    Biomed Mass Spectrom; 1983 Nov; 10(11):586-95. PubMed ID: 6419788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative ion chemical ionization gas chromatography/mass spectrometry of valproic acid metabolites.
    Kassahun K; Burton R; Abbott FS
    Biomed Environ Mass Spectrom; 1989 Oct; 18(10):918-26. PubMed ID: 2508808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy.
    Zhao M; Chen Y; Wang M; Li G; Zhao L
    Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity.
    Fisher E; Siemes H; Pund R; Wittfoht W; Nau H
    Epilepsia; 1992; 33(1):165-71. PubMed ID: 1733752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.
    Kondo T; Otani K; Hirano T; Kaneko S; Fukushima Y
    Br J Clin Pharmacol; 1990 Jan; 29(1):116-9. PubMed ID: 2105099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
    Kassahun K; Farrell K; Abbott F
    Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.